As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
135
The participants will use a portable EEG headband (MUSE) which is a noninvasive tool for collecting EEG data. They will receive real-time EEG data given an audio feedback while doing their daily mindfulness practice.
The participants in this arm will use the portable EEG while listening to an audiobook. They will receive a summary of their brain activities after task completion on each day.
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Migraine Disability
measured by Migraine Disability Assessment Scale (MIDAS)
Time frame: 8 weeks
Migraine Severity
measured by Headache Impact Test-short form (HIT-6)
Time frame: 8 weeks
Headache management self-efficacy
measured by Headache Management Self-Efficacy Scale
Time frame: 8 weeks
Dependence on medicine
measured by Severity of Dependence Scale (SDS)
Time frame: 8 weeks
Anxiety
measured by BECK Anxiety Inventory (BAI)
Time frame: 8 weeks
Depression
measured by The Center for Epidemiologic Studies Depression (CES-D)
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.